BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 215097)

  • 1. Effects of a dopamine agonist piribedil in depressed patients: relationship of pretreatment homovanillic acid to antidepressant response.
    Post RM; Gerner RH; Carman JS; Gillin JC; Jimerson DC; Goodwin FK; Bunney WE
    Arch Gen Psychiatry; 1978 May; 35(5):609-15. PubMed ID: 215097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic agonist effects on Parkinsonian clinical features and brain monamine metabolism.
    Rinne UK; Sonninen V; Marttila R
    Adv Neurol; 1975; 9():383-92. PubMed ID: 1096575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain dopamine turnover and the relief of parkinsonism.
    Rinne UK; Sonninen V; Marttila R
    Adv Exp Med Biol; 1977; 90():267-75. PubMed ID: 930747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dopaminergic mechanism in mania.
    Gerner RH; Post RM; Bunney WE
    Am J Psychiatry; 1976 Oct; 133(10):1177-80. PubMed ID: 970489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain dopamine turnover and the relief of parkinsonism.
    Rinne UK; Marttila R; Sonninen V
    Arch Neurol; 1977 Oct; 34(10):626-9. PubMed ID: 907536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495).
    Shopsin B; Gershon S
    Neuropsychobiology; 1978; 4(1):1-14. PubMed ID: 622219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes.
    Bowers MB
    J Nerv Ment Dis; 1974 May; 158(5):325-30. PubMed ID: 4823933
    [No Abstract]   [Full Text] [Related]  

  • 8. [Stimulation of somatotropin hormone by piribedil, a dopaminergic agonist, in endogenous depression. Preliminary study].
    Guillaume R; Charles G; Mesters P; Schittecatte M; Wilmotte J
    Acta Psychiatr Belg; 1988; 88(2):153-61. PubMed ID: 2905110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
    Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
    Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine effects of the dopamine agonist piribedil in depressed patients.
    Joffe RT; Post RM; Ballenger JC; Rebar R; Rakita R; Gold PW
    Clin Neuropharmacol; 1986; 9(5):448-55. PubMed ID: 3768867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
    Post RM; Goodwin FK
    Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087
    [No Abstract]   [Full Text] [Related]  

  • 12. [New therapeutic indications for a dopamine antagonist, Piribedyl].
    Schmitt H; Laubie M; Poignant JC; Krikorian A; Evrard Y; Freyria JL; Arnaud F
    Sem Hop; 1978 Mar; 54(5-8):325-34. PubMed ID: 211628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.
    Leckman JF; Cohen DJ; Shaywitz BA; Caparulo BK; Heninger GR; Bowers MB
    Arch Gen Psychiatry; 1980 Jun; 37(6):677-81. PubMed ID: 6155891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF monoamine metabolites in mania.
    Swann AC; Secunda S; Davis JM; Robins E; Hanin I; Koslow SH; Maas JW
    Am J Psychiatry; 1983 Apr; 140(4):396-400. PubMed ID: 6188381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of peripheral decarboxylase inhibition on HVA and 5HIAA in cerebrospinal fluid of depressed patients.
    Gaillard JM; Constantinidis J; Tissot R
    Neuropsychobiology; 1975; 1(1):26-31. PubMed ID: 1223666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients.
    Kirstein L; Bowers MB; Heninger G
    Biol Psychiatry; 1976 Aug; 11(4):421-34. PubMed ID: 963133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
    Mendlewicz J; Vanderheyden JE; Noel G
    Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT.
    Abrams R; Essman WB; Taylor MA; Fink M
    Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polygraphic, clinical and therapeutic markers of dopamine-dependent depressions].
    Mouret J; Lemoine P; Minuit MP
    C R Acad Sci III; 1987; 305(8):301-6. PubMed ID: 3115502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Piribedil, dopaminergic agonist. Prolonged clinical and electrophysiological study in 60 parkinsonian patients (author's transl)].
    Truelle JL; Chanelet J; Bastard J; Six P; Emile J
    Nouv Presse Med; 1977 Oct; 6(33):2987-90. PubMed ID: 22844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.